HER2 Status Best Predicts Benefit of Anti-HER2 Therapy

SAN ANTONIO (IMNG) - A variety of biomarkers failed to improve on the results of tumor HER2 status for predicting the benefits of therapy targeting HER2 signaling, based on an analysis of data from the...

Source: OncologySTAT Latest News - January 25, 2013 Category: Cancer & Oncology Source Type: news